Skip to main content

Published locations for Switching to lapatinib shows promise in HER2+ trastuzumab-refractory metastatic breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Switching to lapatinib shows promise in HER2+ trastuzumab-refractory metastatic breast cancer

User login

  • Reset your password
  • /content/switching-lapatinib-shows-promise-her2-trastuzumab-refractory-metastatic-breast-cancer
  • /hematology-oncology/article/254055/breast-cancer/switching-lapatinib-shows-promise-her2-trastuzumab
  • /breast-cancer-icymi/article/254055/breast-cancer/switching-lapatinib-shows-promise-her2-trastuzumab